Document:

Exhibit 10.1

 

seqll
inc.

2014 EQUITY INCENTIVE PLAN

 

As Amended and Restated effective on the
IPO Date

 

SECTION
1.          GENERAL PURPOSE OF THE PLAN; DEFINITIONS

 

The name of the plan
is the 2014 Equity Incentive Plan (the “Plan”). The purpose of the Plan is to encourage and enable the officers,
employees, directors and other key persons (including consultants and prospective employees) of SeqLL Inc., a Delaware corporation
(including any successor entity, the “Company”), and its Subsidiaries upon whose judgment, initiative and efforts
the Company largely depends for the successful conduct of its business to acquire a proprietary interest in the Company. It is
anticipated that providing such persons with a direct stake in the Company’s welfare will assure a closer identification
of their interests with those of the Company and its stockholders, thereby stimulating their efforts on the Company’s behalf
and strengthening their desire to remain with the Company. The Plan was amended and restated effective on the IPO Date to make
certain revisions in anticipation of the Company’s initial public offering.

 

The following terms
shall be defined as set forth below:

 

“409A Affiliate”
means any corporation or other entity in an unbroken chain of corporations or other entities, beginning with the Company, in which
each corporation or other entity (other than the last corporation or entity in the chain) has a controlling interest (within the
meaning of Treasury regulation §1.414(c)-2(b)(2)(i) except that the language at “least 50 percent” shall be used
in place of “at least 80 percent” each place it appears therein) in the corporation or other entity.

 

“Act”
means the Securities Act of 1933, as amended from time to time, and the rules and regulations thereunder. Any reference to a specific
provision in the Act shall include any successor provision thereto.

 

“Affiliate”
has the meaning ascribed to such term in Rule 12b-2 under the Exchange Act. Notwithstanding the foregoing, for purposes of determining
those individuals to whom an Option may be granted, the term “Affiliate” means any entity that, directly indirectly,
through one or more intermediaries, controls, is controlled by or is under common control with the Company within the meaning of
Sections 414(b) or (c) of the Code; provided that, in applying such provisions, the phrase “at least 50 percent” shall
be used in place of “at least 80 percent” each place it appears therein.

 

“Award”
or “Awards,” except where referring to a particular category of grant under the Plan, shall include
Incentive Stock Options, Non-Qualified Stock Options, Restricted Stock Awards, Unrestricted Stock Awards, Restricted Stock Units,
or any combination of the foregoing.

 

“Board”
means the Board of Directors of the Company.

 

    	 	 	 

     

    

 

“Cause”
shall have the meaning set forth in the applicable Grantee’s employment offer letter, severance letter or services agreement,
or if the Grantee does not have an employment offer letter, severance agreement or services agreement with the Company (or the
term “Cause” is not otherwise defined in any of the foregoing), then, unless otherwise defined in any Award agreement,
Cause shall mean a vote of the Board resolving that the Grantee should be dismissed as a result of: (i) the commission of any act
by the Grantee constituting financial dishonesty against the Company or its Subsidiaries (which act would be chargeable as a crime
under applicable law); (ii) the Grantee engaging in any other act of dishonesty, fraud, intentional misrepresentation, moral turpitude,
illegality or harassment which, as determined in good faith by the Board, would: (A) materially adversely affect the business or
the reputation of the Company or any of its Subsidiaries with their respective current or prospective customers, suppliers, lenders
and/or other third parties with whom such entity does or might do business; or (B) expose the Company or any of its Subsidiaries
to a risk of civil or criminal legal damages, liabilities or penalties; (iii) the repeated failure by the Grantee to follow the
directives of the chief executive officer of the Company or any of its Subsidiaries or Board; or (iv) any material misconduct,
violation of the Company’s or Subsidiaries’ policies, or willful and deliberate non-performance of duty by the Grantee
in connection with the business affairs of the Company or its Subsidiaries.

 

“Code”
means the Internal Revenue Code of 1986, as amended, and any successor Code, and related rules, regulations and interpretations
promulgated thereunder. Any reference to a specific provision in the Code shall include any successor provision thereto.

 

“Committee”
means the compensation committee of the Board, each member of which shall qualify as a “nonemployee director” within
the meaning of Rule 16b-3 of the Exchange Act.

 

“Dividend Equivalent Unit”
means the right to receive a payment, in cash or Shares, equal to the cash dividends or other cash distributions paid with respect
to a Share. Dividend Equivalent Units may only be granted in connection with a grant of Restricted Stock Units according to the
terms of Section 9.

 

“Exchange
Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder. Any reference
to a specific provision in the Exchange Act shall include any successor provision thereto.

 

“Fair Market
Value” means, per Share on a particular date: (i) if the Shares are listed on a national securities exchange or a
national market system, the closing sale price of a Share on the immediately preceding trading day on the national securities exchange
on which the Stock is then traded; or (ii) if the Shares are not listed on a national securities exchange, but are traded in an
over-the-counter market, the last sales price (or, if there is no last sales price reported, the average of the closing bid and
asked prices) for the Shares on the immediately preceding trading day; or (iii) if the Shares are neither listed on a national
securities exchange nor traded in an over-the-counter market, the price determined by the Committee, in its discretion, using a
reasonable valuation method within the meaning of Code Section 409A. Notwithstanding the foregoing, in the case of the sale of
Shares, the actual sale price shall be the Fair Market Value of such Shares.

 

    	 	2 	 

     

    

 

“Grantee”
means a Person who has been granted an Award under this Plan.

 

“Incentive
Stock Option” means any Stock Option so designated by the Committee and otherwise qualified as an “incentive
stock option” as defined in Section 422 of the Code.

 

“IPO Date”
means the date on which the Shares are first sold to the public pursuant to an effective registration statement filed by the Company
under the Act.

 

“Non-Qualified
Stock Option” means any Stock Option that is not an Incentive Stock Option.

 

“Person”
shall have the meaning provided in Section 3(a)(9) of the Exchange Act and used in Sections 13(d) and 14(d) thereof, including
a “group” as defined in Section 13(d).

 

“Option”
or “Stock Option” means the right to purchase Shares at a stated price for a specified period of time.
An Option may either be an Incentive Stock Option or a Non-Qualified Stock Option.

 

“Restricted
Stock” means Shares that are subject to a risk of forfeiture or restrictions on transfer which may lapse upon the
completion of a period of service, achievement of performance goals, or a combination thereof.

 

“Restricted
Stock Unit” means the right to receive one Share or a cash payment, the value of which is equal to the Fair Market
Value of one Share.

 

“Sale Event”
shall be deemed to have occurred as of the first day that any one or more of the following conditions is satisfied, including,
but not limited to, the signing of documents by all parties and approval by all regulatory agencies, if required:

 

(i)          Any
Person becomes the “beneficial owner” (as such term is defined pursuant to rules promulgated under the Exchange Act),
directly or indirectly, of securities of the Company representing fifty percent (50%) or more of the combined voting power of the
Company’s then outstanding securities (not including (A) any securities of the Company acquired and/or beneficially owned
by such Person if such Person is an existing stockholder of the Company and (B) any securities acquired directly from the Company
or its Affiliates);

 

(ii)         The
stockholders approve a plan of complete liquidation or dissolution of the Company;

 

(iii)        The
consummation of (A) an agreement for the sale or disposition of all or substantially all of the Company’s assets (other than
to an Excluded Person); or (B) a merger, consolidation or reorganization of the Company with or involving any other corporation,
other than (1) a merger, consolidation or reorganization that would result in the voting securities of the Company outstanding
immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities
of the surviving entity), at least fifty percent (50%) of the combined voting power of the voting securities of the Company (or
such other surviving entity) outstanding immediately after such merger, consolidation or reorganization, or (2) a merger, consolidation
or reorganization that would result in at least fifty percent (50%) of the combined voting power of the voting securities of the
Company (or such other surviving entity) outstanding immediately after such merger, consolidation or reorganization being held
by an Excluded Person; or

 

    	 	3 	 

     

    

 

(iv)        the
following individuals cease for any reason to constitute a majority of the number of directors of the Company then serving: (A)
individuals who, on the IPO Date, constituted the Board and (B) any new director (other than a director whose initial assumption
of office is in connection with an actual or threatened election contest, including but not limited to a consent solicitation,
relating to the election of directors of the Company, as such terms are used in Rule 14a-11 of Regulation 14A under the Exchange
Act) whose appointment or election by the Board or nomination for election by the Company’s shareholders was approved by
a vote of at least two-thirds (2/3) of the directors then still in office who either were directors on the IPO Date, or whose appointment,
election or nomination for election was previously so approved (collectively the “Continuing Directors”); provided,
however, that individuals who are appointed to the Board pursuant to or in accordance with the terms of an agreement relating to
a merger, consolidation, or share exchange involving the Company (or any direct or indirect subsidiary of the Company) shall not
be Continuing Directors for purposes of this definition until after such individuals are first nominated for election by a vote
of at least two-thirds (2/3) of the then Continuing Directors and are thereafter elected as directors by the shareholders of the
Company at a meeting of shareholders held following consummation of such merger, consolidation, or share exchange; and, provided
further, that in the event the failure of any such persons appointed to the Board to be Continuing Directors results in a Sale
Event, the subsequent qualification of such persons as Continuing Directors shall not alter the fact that a Sale Event occurred;

 

An “Excluded
Person” means: (i) the Company or any of its Affiliates; (ii) a trustee or other fiduciary holding securities under any
employee benefit plan of the Company or any of its Affiliates; (iii) an underwriter temporarily holding securities pursuant to
an offering of such securities; or (iv) a corporation owned, directly or indirectly, by the stockholders of the Company in substantially
the same proportions as their ownership of stock in the Company.

 

Notwithstanding the
foregoing, with respect to an Award that is considered deferred compensation subject to Code Section 409A, if the occurrence of
a “Sale Event” triggers payment under such Award, then the foregoing definition shall be deemed amended to the minimum
extent necessary, if at all, so that the definition satisfies the requirements of a change of control under Code Section 409A.

 

“Service
Relationship” means service to the Company or its successors or Subsidiaries as an employee, director or key person
(including as an advisor or consultant).

 

“Shares”
means Shares.

 

“Stock”
means the Common Stock, par value $0.00001 per stock, of the Company, subject to adjustments pursuant to Section 3.

 

    	 	4 	 

     

    

 

“Subsidiary”
means any corporation in an unbroken chain of entities beginning with the Company if each of the corporations (other than the last
corporation in the chain) owns stock possessing more than fifty percent (50%) of the total combined voting power of all classes
of stock in one of the other corporations in the chain.

 

“Termination
Event” means the termination of the Grantee’s Service Relationship with the Company and its Subsidiaries for
any reason whatsoever, regardless of the circumstances thereof, and including, without limitation, upon death, disability, retirement,
discharge or resignation for any reason, whether voluntarily or involuntarily. The following shall not constitute a Termination
Event: (i) a transfer to the employment of the Company from a Subsidiary or from the Company to a Subsidiary, or from one Subsidiary
to another Subsidiary; or (ii) an approved leave of absence for military service or sickness, or for any other purpose approved
by the Committee, if the employee’s right to re-employment is guaranteed either by a statute or by contract or under the
policy pursuant to which the leave of absence was granted or if the Committee otherwise so provides in writing. Notwithstanding
the foregoing, with respect to an Award that is considered deferred compensation subject to Code Section 409A, if the occurrence
of a “Termination Event” triggers payment under such Award, then the foregoing definition shall be deemed amended to
the minimum extent necessary, if at all, so that the definition satisfies the requirements of a separation from service under Code
Section 409A. Notwithstanding any other provision in this Plan or an Award to the contrary, if any Grantee is a “specified
employee” within the meaning of Code Section 409A as of the date of his or her “separation from service” within
the meaning of Code Section 409A, then, to the extent required by Code Section 409A, any payment made to the Grantee on account
of such separation from service shall not be made before a date that is six (6) months after the date of the separation from service.

 

“Unrestricted
Stock Award” means an Award of Shares that are not subject to any transfer restriction or any service requirement,
performance requirement, or other vesting criteria, granted pursuant to Section 8.

 

SECTION
2.          ADMINISTRATION OF PLAN; COMMITTEE AUTHORITY TO SELECT GRANTEES
AND DETERMINE AWARDS

 

(a)          Administration
of Plan. The Plan shall be administered by the Committee, provided, however, that if at any time the Committee shall
not be in existence, then the Board shall administer the Plan. In addition, to the extent applicable law permits, the Board may
delegate any of its authority hereunder to another committee of the Board or one or more officers of the Company, and the Committee
may delegate any of its authority hereunder to a sub-committee or to one or more officers of the Company, provided that no such
delegation is permitted with respect to Awards made to individuals who are subject to Section 16 of the Exchange Act at the time
any such delegated authority or responsibility is exercised unless the delegation is to another committee of the Board consisting
entirely of “nonemployee directors” within the meaning of Rule 16b-3 of the Exchange Act. All references herein to
the Committee shall be deemed to refer to the group then responsible for administration of the Plan at the relevant time (i.e.,
either the Board of Directors, the Committee, or any other committee, sub-committee or officer that the Board or the Committee
delegates its authority to pursuant to this Section 2(a) to the extent of such delegation).

 

    	 	5 	 

     

    

 

(b)          Powers
of Committee. The Committee shall have the power and authority to grant Awards consistent with the terms of the Plan, including
the power and authority:

 

(i)          to
select the individuals to whom Awards may from time to time be granted;

 

(ii)         to
determine the time or times of grant, and the extent, if any, of Incentive Stock Options, Non-Qualified Stock Options, Restricted
Stock Awards, Unrestricted Stock Awards or any combination of the foregoing, granted to any one or more Grantees;

 

(iii)        to
determine the number of Shares to be covered by any Award;

 

(iv)        to
determine and modify from time to time the terms and conditions, including restrictions, not inconsistent with the terms of the
Plan, of any Award, which terms and conditions may differ among individual Awards and Grantees, and to approve the form of written
instruments evidencing the Awards;

 

(v)         to
accelerate at any time the exercisability or vesting of all or any portion of any Award;

 

(vi)        to
impose any limitations on Awards granted under the Plan, including limitations on transfers, repurchase provisions and the like
and to exercise repurchase rights or obligations;

 

(vii)       subject
to any restrictions applicable to Incentive Stock Options, to extend at any time the period in which Stock Options may be exercised;
and

 

(viii)      at
any time to adopt, alter and repeal such rules, guidelines and practices for administration of the Plan and for its own acts and
proceedings as it shall deem advisable; to interpret the terms and provisions of the Plan and any Award (including related written
instruments); to make all determinations it deems advisable for the administration of the Plan; to decide all disputes arising
in connection with the Plan; and to otherwise supervise the administration of the Plan.

 

All decisions, interpretations
and other actions of the Committee shall be binding on all Grantees and any other individual with a right under the Plan.

 

(c)          Indemnification.
Neither the Board nor the Committee, nor any member of either or any delegatee thereof, shall be liable for any act, omission,
interpretation, construction or determination made in good faith in connection with the Plan, and the members of the Board and
the Committee (and any delegatee thereof) shall be entitled in all cases to indemnification and reimbursement by the Company in
respect of any claim, loss, damage or expense (including, without limitation, reasonable attorneys’ fees) arising or resulting
therefrom to the fullest extent permitted by law and/or under any directors’ and officers’ liability insurance coverage
which may be in effect from time to time.

 

    	 	6 	 

     

    

 

SECTION
3.       STOCK ISSUABLE UNDER THE PLAN; DEPLETION OF RESERVE; REPLENISHMENT
OF SHARES; CHANGES IN STOCK; SUBSTITUTION

 

(a)          Stock
Issuable. The maximum number of Shares reserved and available for issuance under the Plan shall be Three Million Five Hundred
Thousand (3,500,000) Shares, subject to adjustment as provided in Section 3(e), all of which may be issued pursuant to Incentive
Stock Options. The Shares available for issuance under the Plan may be authorized but unissued Shares or Shares reacquired by the
Company and held in its treasury.

 

(b)          Depletion
of Reserve. The aggregate number of Shares reserved under Section 3(a) shall be depleted on the date of grant of an Award by
the maximum number of Shares, if any, that may be issuable under an Award as determined at the time of grant. For the avoidance
of doubt, Awards that may only be settled in cash (determined at the time of grant) shall not deplete the Share reserve.

 

(c)          Replenishment of Shares Under this Plan.
If (i) an Award lapses,
expires, terminates or is cancelled without the issuance of Shares under the Award (whether due currently or on a deferred basis),
(ii) it is determined during or at the conclusion of the term of an Award that all or some portion of the Shares with respect
to which the Award was granted will not be issuable on the basis that the conditions for such issuance will not be satisfied,
(iii) Shares are forfeited under an Award, (iv) Shares are issued under any Award and the Company subsequently reacquires them
pursuant to rights reserved upon the issuance of the Shares, (v) an Award or a portion thereof is settled in cash, or shares are
withheld by the Company in payment of the exercise price ir withholding taxes of an Award, then such Shares shall be recredited
to the Plan’s reserve and may again be used for new Awards under this Plan, but Shares recredited to the Plan’s reserve
pursuant to clause (iv) may not be issued pursuant to Incentive Stock Options.

 

(e)          Changes
in Stock.

 

(i)          General
Adjustment Provisions. If, as a result of any reorganization, recapitalization, reclassification, stock dividend, stock split,
reverse stock split or other similar change in the Company’s capital stock, the outstanding Shares are increased or decreased
or are exchanged for a different number or kind of shares or other securities of the Company, or additional shares or new or different
shares or other securities of the Company or other non-cash assets are distributed with respect to such Shares or other securities,
or, if, as a result of any merger, consolidation or sale of all or substantially all of the assets of the Company, the outstanding
Shares are converted into or exchanged for a different number or kind of securities of the Company or any successor entity (or
a parent or subsidiary thereof), the Committee shall make an appropriate or proportionate adjustment in (i) the maximum number
of shares reserved for issuance under the Plan; (ii) the number and kind of shares or other securities subject to any then outstanding
Awards under the Plan; and (iii) the exercise price for each Share subject to any then outstanding Stock Options under the Plan.
The adjustment by the Committee shall be final, binding and conclusive.

 

    	 	7 	 

     

    

The Committee
may also adjust the number of shares subject to outstanding Awards and the exercise price and the terms of outstanding Awards to
take into consideration material changes in accounting practices or principles, extraordinary dividends, acquisitions or dispositions
of stock or property or any other event if it is determined by the Committee that such adjustment is appropriate to avoid distortion
in the operation of the Plan, provided that no such adjustment shall be made in the case of an Incentive Stock Option, without
the consent of the grantee, if it would constitute a modification, extension or renewal of the Option within the meaning of Section 424(h)
of the Code or would violate Section 422(d) of the Code.

 

(ii)         Special
Rules for Certain Awards. With respect to Awards of Incentive Stock Options, all adjustments made pursuant to (i) to must comply
with the adjustment provisions in Code Section 422(b), and any adjustment made pursuant to this Section 3(e) to an Award that
is exempt from Section 409A of the Code shall be made in manner that permits the Award to continue to be so exempt, and any adjustment
to an Award that is subject to Section 409A of the Code shall be made in a manner that complies with the provisions thereof.

 

(iii)        No
Fractional Shares. No fractional Shares shall be issued under the Plan resulting from any such adjustment. The Committee may,
in its discretion, make a cash payment in lieu of fractional shares or cancel such fractional shares for no consideration.

 

(iv)        Certain
Adjustments Automatic. Notwithstanding the foregoing, in the case of a stock dividend (other than a stock dividend declared
in lieu of an ordinary cash dividend) or subdivision or combination of the Shares (including a reverse stock split), if no action
is taken by the Committee, adjustments contemplated by this subsection that are proportionate shall nevertheless automatically
be made as of the date of such stock dividend or subdivision or combination of the Shares.

 

(f)          Substitute
Awards. The Committee may grant Awards under the Plan in substitution for stock and stock based awards held by employees, directors
or other key persons of another corporation in connection with a merger or consolidation of the employing corporation with the
Company or a Subsidiary or the acquisition by the Company or a Subsidiary of property or stock of the employing corporation. The
Committee may direct that the substitute awards be granted on such terms and conditions as the Committee considers appropriate
in the circumstances. Any substitute Awards granted under the Plan shall not count against the share limitation set forth in Section 3(a).

 

SECTION
4.          TREATMENT UPON SALE EVENT

 

(a)          Effect
of a Sale Event. The Committee may specify in an agreement relating to an Award the effect of a Sale Event upon such Award.
If such agreement, or any other agreement between the Grantee and the Company or an Affiliate, does not specify the effect of a
Sale Event on the Award, then:

 

    	 	8 	 

     

    

(i)          Upon
such Sale Event, if the successor or surviving corporation (or parent thereof) so agrees, then, without the consent of any Grantee
(or other person with rights in an Award), some or all outstanding Awards may be assumed, or replaced with the same type of award
with similar terms and conditions, by the successor or surviving corporation (or parent thereof) in the Sale Event. If applicable,
each Award which is assumed by the successor or surviving corporation (or parent thereof) shall be appropriately adjusted, immediately
after such Sale Event, to apply to the number and class of securities which would have been issuable to the Grantee upon the consummation
of such Sale Event had the Award been exercised, vested or earned immediately prior to such Sale Event, and such other appropriate
adjustments in the terms and conditions of the Award shall be made. If the Grantee experiences a Termination Event due to (A) the
successor or surviving corporation terminating the Grantee’s service without Cause, (B) by reason of the Grantee’s
death or Disability, or (C) by the Grantee resigning for “good reason,” as defined in any employment, retention, change
of control, severance or similar agreement between the Grantee and the Company or any Affiliate, if any, in any case within twenty-four
(24) months following the Sale Event, all of the Grantee’s Awards that are in effect as of the date of such Termination Event
shall be vested in full or deemed earned in full (assuming target performance goals provided under such Award were met, if applicable)
effective on the date of such Termination Event.

 

(ii)         To
the extent the purchaser, successor or surviving entity (or parent thereof) in the Sale Event does not assume the Awards or issue
replacement awards as provided in clause (i), then immediately prior to the effective date of the Sale Event:

 

(A)         Each
Option that is then held by a Grantee who has a Service Relationship with Company or an Affiliate on the effective date of the
Sale Event shall become immediately and fully vested, and, unless otherwise determined by the Board or Committee, all Options shall
be cancelled on the date of the Sale Event in exchange for a cash payment equal to the excess of the Sale Price (as defined below)
of the Shares covered by the Option that is so cancelled over the exercise price of such Shares under the Option; provided,
however, that all Options that have an exercise price that is less than the Sale Price shall be cancelled for no consideration.

 

(B)         Restricted
Stock and Restricted Stock Units (that are not subject to any performance goals) that are not then vested shall vest in full and
be settled, and any Dividend Equivalent Units that are not vested shall vest (to the same extent as the Restricted Stock Units
to which they relate) and be paid; and

 

(C)         All
Awards subject to performance goals that are earned but not yet paid shall be paid, and all Awards subject to performance goals
for which the performance period has not expired shall be cancelled in exchange for a cash payment equal to the amount that would
have been due under such Award(s) assuming target performance goals provided under such Award were met, if applicable (or, if higher,
based on actual performance through the date of such Sale Event).

 

    	 	9 	 

     

    

“Sale Price” shall the per Share
price paid or deemed paid in the Sale Event, as determined by the Committee. For purposes of this clause (ii), if the value of
an Award is based on the Fair Market Value of a Share, Fair Market Value shall be deemed to mean the Sale Price.

 

(b)          Certain
Limits on Payments. Solely with respect to awards granted on and after the IPO Date, and except as otherwise expressly provided
in any agreement between a Grantee and the Company or an Affiliate, if the receipt of any payment by a Grantee under the circumstances
described above would result in the payment by the Grantee of any excise tax provided for in Section 280G and Section 4999 of the
Code, then the amount of such payment shall be reduced to the extent required to prevent the imposition of such excise tax.

 

SECTION
5.          ELIGIBILITY

 

(a) General.
Grantees under the Plan will be such full or part-time officers, employees, directors and key persons (including advisors and consultants)
of the Company or a 409A Affiliate as are selected from time to time by the Committee in its sole discretion; provided that if
a Stock Option is granted to any individual who does not provide services to the Company or a 409A Affiliate then such Stock Option
shall be considered nonqualified deferred compensation subject to the provisions of Section 409A of the Code to the extent so required
therein.

 

(b) Limits on Director
Awards. The maximum value of Awards granted during a single fiscal year to any non-employee Director, taken together with any
cash fees paid during the fiscal year to the non-employee Director in respect of the Director’s service as a member of the
Board during such year (including service as a member or chair of any committees of the Board), shall not exceed (i) $800,000 in
total value for the first fiscal year in which the Director first serves as a member of the Board or (ii) $400,000 in total value
for any subsequent fiscal year in which the Director serves as a member of the Board (in each case calculating the value of any
such Awards based on the grant date fair value of such Awards for financial reporting purposes).

 

SECTION
6.          STOCK OPTIONS

 

(a)          Nature
of Stock Options. A Stock Option is an Award entitling the recipient to acquire Shares, at such exercise price as determined
by the Committee and subject to such restrictions and conditions as the Committee may determine at the time of grant. Conditions
may be based on continuing employment (or other Service Relationship) and/or achievement of pre-established performance goals and
objectives. The grant of a Stock Option shall be evidenced by a Stock Option agreement. The terms and conditions of each such agreement
shall be determined by the Committee, and such terms and conditions may differ among individual Awards and Grantees.

 

Stock Options granted
under the Plan may be either Incentive Stock Options or Non-Qualified Stock Options. Incentive Stock Options may be granted only
to employees of the Company or any Subsidiary that is a “subsidiary corporation” within the meaning of Section 424(f)
of the Code. To the extent that any Option does not qualify as an Incentive Stock Option, it shall be deemed a Non-Qualified Stock
Option.

 

    	 	10 	 

     

    

(b)          Grants
of Stock Options. The Committee in its discretion may grant Stock Options to eligible directors, officers, employees and key
persons of the Company or any Subsidiary. Stock Options granted under the Plan shall be subject to the following terms and conditions
and shall contain such additional terms and conditions, not inconsistent with the terms of the Plan, as the Committee shall deem
desirable. If the Committee so determines, Stock Options may be granted in lieu of cash compensation at the Grantee’s election,
subject to such terms and conditions as the Committee may establish.

 

(i)          Exercise
Price. The exercise price per Share covered by a Stock Option granted under the Plan shall be determined by the Committee at
the time of grant but shall not be less than 100% of the Fair Market Value on the date of grant. If an employee owns or is deemed
to own (by reason of the attribution rules of Section 424(d) of the Code) more than 10% of the combined voting power of all
classes of stock of the Company or any Subsidiary (a “10% Owner”) is granted an Incentive Stock Option, then
the exercise price of such Incentive Stock Option shall be not less than 110% of the Fair Market Value on the grant date.

 

(ii)         Option
Term. The term of each Stock Option shall be fixed by the Committee, but any Stock Option shall be exercisable within ten (10)
years after the date the Stock Option is granted. If an employee that is a 10% Owner is granted an Incentive Stock Option, then
the term of such Incentive Stock Option shall be no more than five (5) years from the date of grant.

 

(iii)        Exercisability;
Rights of a Stockholder. Stock Options shall become exercisable at such time or times, whether or not in installments, as shall
be determined by the Committee at or after the grant date and set forth in the Stock Option agreement. The Committee may at any
time accelerate the exercisability of all or any portion of any Stock Option. A Grantee shall have the rights of a stockholder
only as to shares acquired upon the exercise of a Stock Option and not as to unexercised Stock Options. A Grantee shall not be
deemed to have acquired any such shares unless and until a Stock Option shall have been exercised pursuant to the terms hereof,
the Company shall have issued and delivered the Shares to the Grantee, and the Grantee’s name shall have been entered on
the books of the Company as a stockholder.

 

(iv)        Method
of Exercise. Stock Options may be exercised in whole or in part, by giving written notice of exercise to the Company, specifying
the number of shares to be purchased, or by such other method as provided in a Stock Option agreement. Payment of the aggregate
exercise price may be made by one or more of the following methods or as otherwise provided by the Committee:

 

(A)         In
cash, by certified or bank check or other instrument acceptable to the Committee in U.S. funds payable to the order of the Company;

 

(B)         If
permitted by the Committee, through the delivery (or attestation to the ownership) of Shares that are beneficially owned by the
Grantee and are not then subject to restrictions under any Company plan having a Fair Market Value on the exercise date equal to
the aggregate exercise price; or

 

    	 	11 	 

     

    

(C)         If
permitted by the Committee, by having the Company withhold a number of Shares otherwise issuable upon exercise of the Stock Option
having a Fair Market Value on the exercise date equal to the aggregate exercise price.

 

No Shares so purchased
will be issued to the Grantee until the Company has completed all steps required by law to be taken in connection with the issuance
and sale of the Shares, including, without limitation, obtaining from the Grantee payment or provision for all withholding taxes
due as a result of the exercise of the Option and payment of the aggregate exercise price. In the event a Grantee chooses to pay
the aggregate exercise price by previously-owned Shares through the attestation method, the number of Shares transferred to the
Grantee upon the exercise of the Stock Option shall be net of the number of shares attested to.

 

(c)          Annual
Limit on Incentive Stock Options. If the aggregate Fair Market Value (determined as of the time of grant) of the Shares with
respect to which Incentive Stock Options granted under this Plan and any other plan of the Company or its parent and subsidiary
corporations become exercisable for the first time by a Grantee during any calendar year exceed $100,000, such Stock Option shall
constitute a Non-Qualified Stock Option to the extent that this limit is exceeded.

 

SECTION
7.          RESTRICTED STOCK AWARDS

 

(a)          Nature
of Restricted Stock Awards. A Restricted Stock Award is a grant (or sale, at such purchase price as determined by the Committee,
in its sole discretion) of Shares that are subject to such restrictions and conditions as the Committee may determine at the time
of grant. Conditions may be based on continuing employment (or other Service Relationship) and/or achievement of pre-established
performance goals and objectives. The grant of a Restricted Stock Award will be evidenced by a Restricted Stock Award agreement.
The terms and conditions of each such agreement shall be determined by the Committee, and such terms and conditions may differ
among individual Awards and Grantees.

 

(b)          Rights
as a Stockholder. Except as otherwise provided in any Restricted Stock Award agreement, the Grantee shall be (i) considered
the record owner of and shall be entitled to vote the Shares of Restricted Stock if and to the extent such Shares are entitled
to voting rights and (ii) entitled to receive all dividends and any other distributions declared on the Shares; provided, however,
that the Company is under no duty to declare any such dividends or to make any such distribution, and provided further that
any dividends paid on Restricted Stock that is granted on and after the IPO Date will be accumulated and paid if and only to the
same extent as the Restricted Stock vests.

 

(c)          Vesting
of Restricted Stock. The Committee at the time of grant shall specify the date or dates and/or the attainment of pre-established
performance goals, objectives and other conditions on which Restricted Stock shall become vested, subject to such further rights
of the Company or its assigns as may be specified in the instrument evidencing the Restricted Stock Award.

 

    	 	12 	 

     

    

 

SECTION
8.          UNRESTRICTED STOCK AWARDS

 

(a)          Grant
or Sale of Unrestricted Stock. The Committee may, in its sole discretion, grant (or sell at par value or such higher purchase
price determined by the Committee) Unrestricted Shares to any Grantee, in respect of past services, in exchange for cancellation
of a compensation right, as a bonus, or any other valid consideration, or in lieu of any cash compensation due to such individual
in accordance with (b) below.

 

(b)          Elections
to Receive Unrestricted Stock In Lieu of Compensation. Upon the request of a Grantee and with the consent of the Committee,
a Grantee may, pursuant to an advance written election delivered to the Company no later than the date specified by the Committee,
receive a portion of the cash compensation otherwise due to such Grantee in the form of shares of Unrestricted Stock either currently
or on a deferred basis.

 

SECTION
9.          RESTRICTED STOCK UNIT AWARDS

 

(a)          Grant
of Restricted Stock Units. The Committee shall determine all terms and conditions of an award of Restricted Stock Units, including
but not limited to: (i) the number Restricted Stock Units granted; (ii) whether the Restricted Stock Units will be settled in cash,
Shares, or a combination thereof; (iii) whether, as a condition for the Grantee to earn all or a portion of the Restricted Stock
Units, one or more performance goals must be achieved; (iv) the length of the vesting and/or performance period and, if different,
the date on which payment of cash or Shares, as applicable, will be mad; and (v) whether the grant will include the right to receive
Dividend Equivalent Units. The grant of Restricted Stock Units shall be evidenced by a Restricted Stock Unit agreement.

 

(b)          Dividend
Equivalent Units. The Committee shall determine all terms and conditions of an award of Dividend Equivalent Units, including
whether payment will be made in cash or Shares, provided however, that no Dividend Equivalent Units may be paid with respect
to Restricted Stock Units that are not earned or that do not become vested.

 

SECTION
10.         transferability; lockup

 

(a)          Transferability.
Awards are not transferable other than by will or the laws of descent and distribution, unless and to the extent the Committee
allows a Grantee to: (i) designate in writing a beneficiary to exercise the Award or receive payment under the Award after the
Grantee’s death; (ii) transfer an Award to the former spouse of the Grantee as required by a domestic relations order incident
to a divorce; or (iii) transfer an Award; provided, however, that with respect to clause (iii) above the Grantee may not receive
consideration for such a transfer of an Award.

 

    	 	13 	 

     

    

(b)          Lockup
Provision. Each Grantee agrees that he, she or it will not, without the prior written consent of the managing underwriter (if
any), during (i) the period commencing on the IPO Date and ending on the date specified by the Company and/or the managing underwriter
(not to exceed 210 days following the IPO Date); or (ii) during the 90 day period following the effective date of any other registration
statement filed by the Company under the Act: (a) lend, offer, pledge, sell, contract to sell, sell any option or contract to purchase,
purchase any option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, directly
or indirectly, any shares of capital stock held immediately prior to the effectiveness of the applicable registration statement;
or (b) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences
of ownership of the capital stock, whether any such transaction described in clause (a) or (b) above is to be settled by delivery
of capital stock or other securities, in cash or otherwise. The underwriters in connection with any applicable offering and associated
registration statement are intended third-party beneficiaries of this Section 10(b) and shall have the right, power and authority
to enforce the provisions hereof as though they were a party hereto. Each Grantee further agrees to execute such agreements as
may be reasonably requested by the Company and/or the underwriters in connection with any applicable offering and any associated
registration statement that are consistent with this Section 10(b) or that are necessary to give further effect thereto. In order
to enforce the foregoing covenant, the Company may impose stop-transfer instructions with respect to the shares of capital stock
of each Grantee (and transferees and assignees thereof) until the end of such restricted period.

 

If, as a result of any reorganization, recapitalization,
reclassification, stock dividend, stock split, reverse stock split or other similar change in the Common Stock, the outstanding
shares of Common Stock are increased or decreased or are exchanged for a different number or kind of shares of the Company’s
stock, the restrictions contained in this Section 10(b) shall apply with equal force to additional and/or substitute securities,
if any, received by the Grantee in exchange for, or by virtue of his or her ownership of the Shares issued hereunder.

 

SECTION
11.         TAX WITHHOLDING

 

(a)          Payment
by Grantee. Each Grantee shall, no later than the date as of which the value of an Award or of any Stock or other amounts received
thereunder first becomes includable in the gross income of the Grantee for Federal income tax purposes, pay to the Company, or
make arrangements satisfactory to the Committee regarding payment of, any Federal, state, or local taxes of any kind required by
law to be withheld with respect to such income. The Company and its Subsidiaries shall, to the extent permitted by law, have the
right to deduct any such taxes from any payment of any kind otherwise due to the Grantee. The Company’s obligation to issue
Shares to any Grantee is subject to and conditioned on any such tax obligations being satisfied by the Grantee.

 

(b)          Payment
in Stock. If approved by the Committee, a Grantee may elect to satisfy any tax withholding obligations, in whole or in part,
by (i) authorizing the Company to withhold from Shares subject to, or to be issued pursuant to, any Award or (ii) transferring
to the Company Shares that the Grantee beneficially owns, in either case having a Fair Market Value (as of the date the withholding
is effected) equal to the amount to be withheld, provided that the amount to be withheld in Shares may not exceed the total maximum
statutory tax withholding obligations associated with the transaction to the extent needed for the Company and its Affiliates to
avoid an accounting charge.

 

    	 	14 	 

     

    

(c)          No
Guarantee of Tax Treatment. Notwithstanding any provisions of the Plan, the Company does not guarantee to any Grantee or any
other Person with an interest in an Award that any Award intended to be exempt from Section 409A of the Code shall be so exempt,
nor that any Award intended to comply with Section 409A of the Code shall so comply, or any Option intended to qualify as an Incentive
Stock Option so qualifies, nor will the Company or any Affiliate indemnify, defend or hold harmless any individual with respect
to the tax consequences of any such failure.

 

SECTION
12.         AMENDMENTS AND TERMINATION

 

(a)          Term
of Plan. This Plan, as amended and restated, shall become effective upon the IPO Date, provided that the Company’s stockholders
have approved the Plan, as amended and restated, on or prior to such date in accordance with applicable law. The Plan shall continue
until all Shares reserved for issuance hereunder have been issued, or, if earlier, until such time as the Committee terminates
the Plan pursuant to this Section 12. No Incentive Stock Options may be granted after the ten (10) year anniversary of the date
of stockholder approval of the amendment and restatement of the Plan unless the shareholders of the Company have approved an extension
of this Plan for such purpose.

 

(b)          Termination
and Amendment of Plan. The Board may, at any time, amend, terminate or discontinue the Plan, subject to the following limitations:

 

(i)          shareholders
must approve any amendment of this Plan to the extent the Company determines such approval is required by: (A) Section 16
of the Exchange Act, (B) the Code (including, but not limited to Section 422 of the Code), (C) the listing requirements
of any principal securities exchange or market on which the Shares are then traded, or (D) any other applicable law; and

 

(ii)         shareholders
must approve any of the following Plan amendments: (A) an amendment to materially increase any number of Shares reserved for
issuance hereunder (except as permitted by Section 3), or (B) an amendment that would diminish the protections afforded by
Section 12(d).

 

Notwithstanding the foregoing, the authority
of the Board and the Committee to administer the Plan with respect to then-outstanding Awards will extend beyond the date of this
Plan’s termination. In addition, termination of this Plan will not affect the rights of Grantees with respect to Awards previously
granted to them, and all unexpired Awards will continue in force and effect after termination of this Plan except as they may lapse
or be terminated by their own terms and conditions.

 

(c)          Amendment,
Modification, Cancellation and Disgorgement of Awards.

 

(i)          Except
as provided in Section 12(d) and subject to the requirements of this Plan, the Committee may modify, amend or cancel any Award;
provided that, except as otherwise provided in the Plan or the Award agreement, any modification or amendment that materially
diminishes the rights of the Grantee, or the cancellation of an Award, shall be effective only if agreed to by the Grantee or any
other person(s) as may then have an interest in such Award, but the Company need not obtain Grantee (or other interested party)
consent for the modification, amendment or cancellation of an Award pursuant to the provisions of subsection (ii) or Section 3(e),
or Section 4 or as follows: (A) to the extent the Committee deems such action necessary to comply with any applicable law or the
listing requirements of any principal securities exchange or market on which the Shares are then traded; (B) to the extent the
Committee deems necessary to preserve favorable accounting or tax treatment of any Award for the Company; or (C) to the extent
the Committee determines that such action does not materially and adversely affect the value of an Award or that such action is
in the best interest of the affected Grantee (or any other person(s) as may then have an interest in the Award). Notwithstanding
the foregoing, unless determined otherwise by the Committee, any such amendment shall be made in a manner that will enable an Award
intended to be exempt from Code Section 409A to continue to be so exempt, or to enable an Award intended to comply with Code Section
409A to continue to so comply.

 

    	 	15 	 

     

    

 

(ii)         Notwithstanding
anything to the contrary in an Award agreement, the Committee shall have full power and authority to terminate or cause a Grantee
to forfeit the Award, and require a Grantee to disgorge to the Company any gains attributable to the Award, if the Grantee engages
in any action constituting, as determined by the Committee in its discretion, Cause for termination, or a breach of any Award agreement
or any other agreement between the Grantee and the Company or an Affiliate concerning noncompetition, nonsolicitation, confidentiality,
trade secrets, intellectual property, nondisparagement or similar obligations.

 

(iii)        Any
Awards granted pursuant to this Plan, and any Shares issued or cash paid pursuant to an Award, shall be subject to any recoupment
or clawback policy that is adopted by the Company from time to time, or any recoupment or similar requirement otherwise made applicable
to the Company by law, regulation or listing standards.

 

(d)          Repricing
and Backdating Prohibited. Notwithstanding anything in this Plan to the contrary,
and except for the adjustments provided for in Section 3, neither the Committee nor any other person may (i) amend the terms
of outstanding Options to reduce the exercise or grant price of such outstanding Options; (ii) cancel outstanding Options in exchange
for Options with an exercise or grant price that is less than the exercise or grant price of the original Options; or (iii) cancel
outstanding Options with an exercise or grant price above the current Fair Market Value of a Share in exchange for cash or other
securities. In addition, the Committee may not make a grant of an Option with a grant date that is effective prior to the date
the Committee takes action to approve such Award.

 

SECTION
13.         Termination event

 

Except as otherwise provided in any Award
agreement or the Grantee’s employment offer letter, severance letter or services agreement, or as determined by the Committee
at the time of such Termination Event:

 

    	 	16 	 

     

    

(a)          If
a Grantee experiences Termination Event due to Cause, a Grantee shall forfeit all outstanding Awards immediately upon such termination.
For the avoidance of doubt, the Grantee will be prohibited from exercising any Stock Options on and after his or her termination
date.

 

(b)          If
a Grantee experiences a Termination Event due to the Grantee’s death or disability (at a time when the Grantee could not
have been terminated for Cause), the Grantee shall forfeit the unvested portion of any Award, and any vested Options shall remain
exercisable until the earlier of the Option’s original expiration date or twelve (12) months from the date of Grantee’s
termination.

 

(c)          If
a Grantee experiences a Termination Event for any reason other than Cause, death or disability (at a time when the Grantee could
not have been terminated for Cause), then the Grantee shall forfeit the unvested portion of any Award, and any vested Options shall
remain exercisable until the earlier of the Award’s original expiration date or three (3) months from the date of Grantee’s
termination.

 

SECTION
14.         STATUS OF PLAN

 

With respect to the
portion of any Award that has not been exercised and any payments in cash, Stock or other consideration not received by a Grantee,
a Grantee shall have no rights greater than those of a general creditor of the Company unless the Committee shall otherwise expressly
determine in connection with any Award or Awards. In its sole discretion, the Committee may authorize the creation of trusts or
other arrangements to meet the Company’s obligations to deliver Stock or make payments with respect to Awards hereunder,
provided that the existence of such trusts or other arrangements is consistent with the foregoing sentence.

 

SECTION
15.         GENERAL PROVISIONS

 

(a)          No
Distribution; Compliance with Legal Requirements. The Committee may require each person acquiring Stock pursuant to an Award
to represent to and agree with the Company in writing that such person is acquiring the Shares without a view to distribution thereof.
No Shares shall be issued pursuant to an Award until all applicable securities law and other legal requirements have been satisfied.

 

(b)          Delivery
of Stock Certificates; Book Entry; Legends and Stop-Transfer Restrictions. Stock certificates to Grantees under this Plan shall
be deemed delivered for all purposes when the Company or a stock transfer agent of the Company shall have mailed such certificates
in the United States mail, addressed to the Grantee, at the Grantee’s last known address on file with the Company. In addition,
the issuance of Shares under the Plan may be effected on a non-certificated or book-entry basis, to the extent not prohibited or
required by applicable law or listing standards and so long as such issuance is in compliance with the applicable rules of any
stock exchange that the Shares are then traded on. The Company may include appropriate restrictive legends or enter appropriate
stop-transfer orders with respect to Shares issued under the Plan.

 

    	 	17 	 

     

    

(c)          Other
Compensation Arrangements; No Employment Rights. Nothing contained in this Plan shall prevent the Board from adopting other
or additional compensation arrangements, including trusts, and such arrangements may be either generally applicable or applicable
only in specific cases. The adoption of this Plan and the grant of Awards do not confer upon any employee any right to continued
employment with the Company or any Subsidiary.

 

(d)          Designation
of Beneficiary. Each Grantee to whom an Award has been made under the Plan may designate a beneficiary or beneficiaries to
exercise any Award or receive any payment under any Award payable on or after the Grantee’s death. Any such designation shall
be on a form provided for that purpose by the Committee and shall not be effective until received by the Committee. If no beneficiary
has been designated by a deceased Grantee, or if the designated beneficiaries have predeceased the Grantee, the beneficiary shall
be the Grantee’s estate.

 

(e)          409A.
The provisions of Code Section 409A are incorporated into this Plan to the extent necessary for any Award that is subject to Code
Section 409A to comply therewith.

 

(f)          Foreign
Participation. To assure the viability of Awards granted to Grantees employed or residing in foreign countries, the Committee
may provide for such special terms as it may consider necessary or appropriate to accommodate differences in local law, tax policy,
accounting or custom. Moreover, the Committee may approve such supplements to, or amendments, restatements or alternative versions
of, this Plan as it determines is necessary or appropriate for such purposes. Any such amendment, restatement or alternative versions
that the Committee approves for purposes of using this Plan in a foreign country will not affect the terms of this Plan for any
other country. In addition, all such supplements, amendments, restatements or alternative versions must comply with the provisions
of Section 12.

 

SECTION
16.         GOVERNING LAW

 

This Plan and all Awards
and actions taken thereunder shall be governed by, and construed in accordance with, the laws of the State of Delaware, applied
without regard to conflict of law principles.

 

SECTION
17.         dispute resolution

 

(a)          Except
as provided below, any dispute arising out of or relating to this Plan or any Award made hereunder, or any agreement executed in
connection herewith, or the breach, termination or validity of this Plan, any such Award or any such agreement, shall be finally
settled by binding arbitration conducted in accordance with the Rules of Arbitration of the American Arbitration Association (“AAA”)
by three (3) arbitrators appointed in accordance with the said rules unless the parties agree on the name of a sole arbitrator,
and judgment upon the award rendered by the arbitrator(s) may be entered by any court having jurisdiction thereof. The place of
arbitration shall be California.

 

    	 	18 	 

     

    

(b)          The
arbitration shall commence within 60 days of the date on which a written demand for arbitration is filed by any party hereto. In
connection with the arbitration proceeding, the arbitrator shall have the power to order the production of documents by each party
and any third-party witnesses. In addition, each party may take up to three (3) depositions as of right, and the arbitrator may
in his or her discretion allow additional depositions upon good cause shown by the moving party. However, the arbitrator shall
not have the power to order the answering of interrogatories or the response to requests for admission. In connection with any
arbitration, each party to the arbitration shall provide to the other, no later than seven (7) business days before the date of
the arbitration, the identity of all persons that may testify at the arbitration and a copy of all documents that may be introduced
at the arbitration or considered or used by a party’s witness or expert. The arbitrator’s decision and award shall
be made and delivered within six (6) months of the selection of the arbitrator. The arbitrator’s decision shall set forth
a reasoned basis for any award of damages or finding of liability. The arbitrator shall not have power to award damages in excess
of actual compensatory damages and shall not multiply actual damages or award punitive damages, and each party hereby irrevocably
waives any claim to such damages.

 

(c)          The
Company, each recipient of an Award hereunder, each party to an agreement governed hereby and any other holder of Stock issued
under this Plan (each, a “Party”) covenants and agrees that such party will participate in the arbitration in
good faith. This Section 16 applies equally to requests for temporary, preliminary or permanent injunctive relief, except
that in the case of temporary or preliminary injunctive relief any party may proceed in court without prior arbitration for the
limited purpose of avoiding immediate and irreparable harm.

 

(d)          Each
Party (i) hereby irrevocably submits to the jurisdiction of any United States District Court of competent jurisdiction for the
purpose of enforcing the award or decision in any such proceeding; (ii) hereby waives, and agrees not to assert, by way of motion,
as a defense, or otherwise, in any such suit, action or proceeding, any claim that it is not subject personally to the jurisdiction
of the above-named courts, that its property is exempt or immune from attachment or execution (except as protected by applicable
law), that the suit, action or proceeding is brought in an inconvenient forum, that the venue of the suit, action or proceeding
is improper or that this Plan or the subject matter hereof may not be enforced in or by such court; and (iii) hereby waives and
agrees not to seek any review by any court of any other jurisdiction which may be called upon to grant an enforcement of the judgment
of any such court. Each Party hereby consents to service of process by registered mail at the address to which notices are to be
given. Each Party agrees that its, his or her submission to jurisdiction and its, his or her consent to service of process by mail
is made for the express benefit of each other Party. Final judgment against any Party in any such action, suit or proceeding may
be enforced in other jurisdictions by suit, action or proceeding on the judgment, or in any other manner provided by or pursuant
to the laws of such other jurisdiction.

 

    	 	19 	 

     

    

 

	DATE APPROVED BY BOARD OF DIRECTORS:	 

 

	DATE APPROVED BY STOCKHOLDERS:	 

 

    	 	20Exhibit 10.7

 

AMENDED
AND RESTATED

 

RIGHT
OF FIRST REFUSAL AND CO-SALE AGREEMENT

 

     

     

    

 

TABLE OF CONTENTS

 

	 	 	 	Page
	 	 	 	 
	1.	Definitions	1
	 	 	 	 
	2.	Agreement
    Among the Company, the Investors and the Key Holders	3
	 	2.1	Right
    of First Refusal	3
	 	2.2	Right
    of Co-Sale	5
	 	2.3	Effect
    of Failure to Comply	7
	 	 	 
	3.	Exempt
    Transfers	8
	 	3.1	Exempted
    Transfers	8
	 	3.2	Exempted
    Offerings	8
	 	3.3	Prohibited
    Transferees	8
	 	 	 	 
	4.	Legend	9
	 	 	 	 
	5.	Lock-Up	9
	 	5.1	Agreement
    to Lock-Up	9
	 	5.2	Stop
    Transfer Instructions	10
	 	 	 	 
	6.	Miscellaneous	10
	 	6.1	Term	10
	 	6.2	Stock
    Split	10
	 	6.3	Ownership	10
	 	6.4	Dispute
    Resolution	10
	 	6.5	Notices	11
	 	6.6	Entire
    Agreement	11
	 	6.7	Delays
    or Omissions	11
	 	6.8	Amendment;
    Waiver and Termination	12
	 	6.9	Assignment
    of Rights	12
	 	6.10	Severability	13
	 	6.11	Additional
    Investors	13
	 	6.12	Governing
    Law	13
	 	6.13	Titles
    and Subtitles	13
	 	6.14	Counterparts	13
	 	6.15	Aggregation
    of Stock	13
	 	6.16	Specific
    Performance	13

 

Schedule A         
-           Investors

Schedule B          
-          Key Holders

 

    			 

     

    

 

AMENDED AND RESTATED

RIGHT OF FIRST REFUSAL

AND CO-SALE AGREEMENT

 

THIS AMENDED AND RESTATED
RIGHT OF FIRST REFUSAL AND CO-SALE AGREEMENT (this “Agreement”), is made as of the 19th day of February, 2016
by and among SeqLL Inc., a Delaware corporation (the “Company”), the Investors listed on Schedule A
and the Key Holders listed on Schedule B.

 

WHEREAS, the Company,
the Key Holders and certain of the Investors (the “Prior Investors”) previously entered into a Right of First
Refusal and Co-Sale Agreement, dated as of May 30, 2014 (the “Prior Agreement”), in connection with the purchase
of shares of Series A-1 Preferred Stock, par value $0.00001 per share (“Series A-1 Preferred Stock”); and

 

WHEREAS, the Key
Holders, the Prior Investors and the Company desire to induce certain other Investors to purchase shares of Series A-2 Preferred
Stock of the Company, par value $0.00001 per share (“Series A-2 Preferred Stock”), pursuant to the Series A-2
Convertible Preferred Stock Purchase Agreement, dated as of the date hereof, by and among the Company and such Investors (the “Purchase
Agreement”) by amending and restating the Prior Agreement to provide the Investors with the rights and privileges as
set forth herein.

 

NOW, THEREFORE,
the Company, the Key Holders and the Investors each hereby agree as follows:

 

1.            Definitions.

 

1.1       “Affiliate”
means, with respect to any specified Investor, any other Investor who directly or indirectly, controls, is controlled by or is
under common control with such Investor, including, without limitation, any general partner, managing member, officer or director
of such Investor, or any venture capital fund now or hereafter existing which is controlled by one or more general partners or
managing members of, or shares the same management company with, such Investor.

 

1.2       “Capital
Stock” means (a) shares of Common Stock and Preferred Stock (whether now outstanding or hereafter issued in any context),
(b) shares of Common Stock issued or issuable upon conversion of Preferred Stock, and (c) shares of Common Stock issued or issuable
upon exercise or conversion, as applicable, of stock options, warrants or other convertible securities of the Company, in each
case now owned or subsequently acquired by any Key Holder, any Investor, or their respective successors or permitted transferees
or assigns. For purposes of the number of shares of Capital Stock held by an Investor or Key Holder (or any other calculation based
thereon), all shares of Preferred Stock shall be deemed to have been converted into Common Stock at the then-applicable conversion
ratio.

 

1.3       “Change
of Control” means a transaction or series of related transactions in which a person, or a group of related persons, acquires
from stockholders of the Company shares representing more than fifty percent (50%) of the outstanding voting power of the Company.

 

    	 	1	 

     

    

 

1.4       “Common
Stock” means shares of Common Stock of the Company, $0.00001 par value per share.

 

1.5       “Company
Notice” means written notice from the Company notifying the selling Key Holders that the Company intends to exercise
its Right of First Refusal as to some or all of the Transfer Stock with respect to any Proposed Key Holder Transfer.

 

1.6       “Investor
Notice” means written notice from an Investor notifying the Company and the selling Key Holder that such Investor intends
to exercise its Secondary Refusal Right as to a portion of the Transfer Stock with respect to any Proposed Key Holder Transfer.

 

1.7       “Investors”
means the persons named on Schedule A hereto, each person to whom the rights of an Investor are assigned pursuant to
Subsection 6.9, each person who hereafter becomes a signatory to this Agreement pursuant to Subsection 6.11 and any
one of them, as the context may require; provided, however, that any such person shall cease to be considered an
Investor for purposes of this Agreement at any time such person and his, her or its Affiliates collectively hold fewer than 156,250
shares of Capital Stock (as adjusted for any stock combination, stock split, stock dividend, recapitalization or other similar
transaction).

 

1.8       “Key
Holders” means the persons named on Schedule B hereto, each person to whom the rights of a Key Holder are
assigned pursuant to Subsection 3.1, each person who hereafter becomes a signatory to this Agreement pursuant to Subsection
6.9 and any one of them, as the context may require.

 

1.9       “Preferred
Stock” means collectively, all shares of Series A-1 Preferred Stock and Series A-2 Preferred Stock.

 

1.10     “Proposed
Key Holder Transfer” means any assignment, sale, offer to sell, pledge, mortgage, hypothecation, encumbrance, disposition
of or any other like transfer or encumbering of any Transfer Stock (or any interest therein) proposed by any of the Key Holders.

 

1.11     “Proposed
Transfer Notice” means written notice from a Key Holder setting forth the terms and conditions of a Proposed Key Holder
Transfer.

 

1.12     “Prospective
Transferee” means any person to whom a Key Holder proposes to make a Proposed Key Holder Transfer.

 

1.13     “Restated
Certificate” means the Company’s Amended and Restated Certificate of Incorporation, as amended from time to time.

 

1.14     “Right
of Co-Sale” means the right, but not an obligation, of an Investor to participate in a Proposed Key Holder Transfer on
the terms and conditions specified in the Proposed Transfer Notice.

 

1.15     “Right
of First Refusal” means the right, but not an obligation, of the Company, or its permitted transferees or assigns, to
purchase some or all of the Transfer Stock with respect to a Proposed Key Holder Transfer, on the terms and conditions specified
in the Proposed Transfer Notice.

 

    	 	2	 

     

    

 

1.16     “Secondary
Notice” means written notice from the Company notifying the Investors and the selling Key Holder that the Company does
not intend to exercise its Right of First Refusal as to all shares of Transfer Stock with respect to any Proposed Key Holder Transfer.

 

1.17     “Secondary
Refusal Right” means the right, but not an obligation, of each Investor to purchase up to its pro rata portion (based
upon the total number of shares of Capital Stock then held by all Investors) of any Transfer Stock not purchased pursuant to the
Right of First Refusal, on the terms and conditions specified in the Proposed Transfer Notice.

 

1.18     “Transfer
Stock” means shares of Capital Stock owned by a Key Holder, or issued to a Key Holder after the date hereof (including,
without limitation, in connection with any stock split, stock dividend, recapitalization, reorganization, or the like), but does
not include any shares of Preferred Stock or of Common Stock that are issued or issuable upon conversion of Preferred Stock.

 

1.19     “Undersubscription
Notice” means written notice from an Investor notifying the Company and the selling Key Holder that such Investor intends
to exercise its option to purchase all or any portion of the Transfer Stock not purchased pursuant to the Right of First Refusal
or the Secondary Refusal Right.

 

2.            Agreement
Among the Company, the Investors and the Key Holders.

 

2.1       Right
of First Refusal.

 

(a)       Grant.
Subject to the terms of Section 3 below, each Key Holder hereby unconditionally and irrevocably grants to the Company a
Right of First Refusal to purchase all or any portion of Transfer Stock that such Key Holder may propose to transfer in a Proposed
Key Holder Transfer, at the same price and on the same terms and conditions as those offered to the Prospective Transferee.

 

(b)       Notice.
Each Key Holder proposing to make a Proposed Key Holder Transfer must deliver a Proposed Transfer Notice to the Company and each
Investor not later than forty-five (45) days prior to the consummation of such Proposed Key
Holder Transfer. Such Proposed Transfer Notice shall contain the material terms and conditions (including price and form of consideration)
of the Proposed Key Holder Transfer, the identity of the Prospective Transferee and the intended date of the Proposed Key Holder
Transfer. To exercise its Right of First Refusal under this Section 2, the Company must deliver a Company Notice to the
selling Key Holder within fifteen (15) days after delivery of the Proposed Transfer Notice. In the event of a conflict between
this Agreement and any other agreement that may have been entered into by a Key Holder with the Company that contains a preexisting
right of first refusal, the Company and the Key Holder acknowledge and agree that the terms of this Agreement shall control and
the preexisting right of first refusal shall be deemed satisfied by compliance with Subsection 2.1(a) and this Subsection
2.1(b). In the event of a conflict between this Agreement and the Company’s Bylaws containing a preexisting right of
first refusal, the terms of the Bylaws will control and compliance with the Bylaws shall be deemed compliance with this Subsection
2.1(a) and (b) in full.

 

    	 	3	 

     

    

 

(c)       Grant
of Secondary Refusal Right to Investors. Subject to the terms of Section 3 below, each Key Holder hereby unconditionally
and irrevocably grants to the Investors a Secondary Refusal Right to purchase all or any portion of the Transfer Stock not purchased
by the Company pursuant to the Right of First Refusal, as provided in this Subsection 2.1(c). If the Company does not intend
to exercise its Right of First Refusal with respect to all Transfer Stock subject to a Proposed Key Holder Transfer, the Company
must deliver a Secondary Notice to the selling Key Holder and to each Investor to that effect no later than fifteen (15) days after
the selling Key Holder delivers the Proposed Transfer Notice to the Company. To exercise its Secondary Refusal Right, an Investor
must deliver an Investor Notice to the selling Key Holder and the Company within ten (10) days after the Company’s deadline
for its delivery of the Secondary Notice as provided in the preceding sentence.

 

(d)       Undersubscription
of Transfer Stock. If options to purchase have been exercised by the Company and the Investors with respect to some but not
all of the Transfer Stock by the end of the ten (10) day period specified in the last sentence of Subsection 2.1(c) (the
“Investor Notice Period”), then the Company shall, immediately after the expiration of the Investor Notice Period,
send written notice (the “Company Undersubscription Notice”) to those Investors who fully exercised their Secondary
Refusal Right within the Investor Notice Period (the “Exercising Investors”). Each Exercising Investor shall,
subject to the provisions of this Subsection 2.1(d), have an additional option to purchase all or any part of the balance
of any such remaining unsubscribed shares of Transfer Stock on the terms and conditions set forth in the Proposed Transfer Notice.
To exercise such option, an Exercising Investor must deliver an Undersubscription Notice to the selling Key Holder and the Company
within ten (10) days after the expiration of the Investor Notice Period. In the event there are two (2) or more such Exercising
Investors that choose to exercise the last-mentioned option for a total number of remaining shares in excess of the number available,
the remaining shares available for purchase under this Subsection 2.1(d) shall be allocated to such Exercising Investors
pro rata based on the number of shares of Transfer Stock such Exercising Investors have elected to purchase pursuant to the Secondary
Refusal Right (without giving effect to any shares of Transfer Stock that any such Exercising Investor has elected to purchase
pursuant to the Company Undersubscription Notice). If the options to purchase the remaining shares are exercised in full by the
Exercising Investors, the Company shall immediately notify all of the Exercising Investors and the selling Key Holder of that fact.

 

(e)       Forfeiture
of Rights. Notwithstanding the foregoing, if the total number of shares of Transfer Stock that the Company and the Investors
have agreed to purchase in the Company Notice, Investor Notices and Undersubscription Notices is less than the total number of
shares of Transfer Stock, then the Company and the Investors shall be deemed to have forfeited any right to purchase such Transfer
Stock, and the selling Key Holder shall be free to sell all, but not less than all, of the Transfer Stock to the Prospective Transferee
on terms and conditions substantially similar to (and in no event more favorable than) the terms and conditions set forth in the
Proposed Transfer Notice, it being understood and agreed that (i) any such sale or transfer shall be subject to the other terms
and restrictions of this Agreement, including, without limitation, the terms and restrictions set forth in Subsections 2.2
and 6.9(b); (ii) any future Proposed Key Holder Transfer shall remain subject to the terms and conditions of this Agreement,
including this Section 2; and (iii) such sale shall be consummated within forty-five (45) days after receipt of the Proposed
Transfer Notice by the Company and, if such sale is not consummated within such forty-five (45) day period, such sale shall again
become subject to the Right of First Refusal and Secondary Refusal Right on the terms set forth herein.

 

    	 	4	 

     

    

 

(f)       Consideration;
Closing. If the consideration proposed to be paid for the Transfer Stock is in property, services or other non-cash consideration,
the fair market value of the consideration shall be as determined in good faith by the Company’s Board of Directors and as
set forth in the Company Notice. If the Company or any Investor cannot for any reason pay for the Transfer Stock in the same form
of non-cash consideration, the Company or such Investor may pay the cash value equivalent thereof, as determined in good faith
by the Board of Directors and as set forth in the Company Notice. The closing of the purchase of Transfer Stock by the Company
and the Investors shall take place, and all payments from the Company and the Investors shall have been delivered to the selling
Key Holder, by the later of (i) the date specified in the Proposed Transfer Notice as the intended date of the Proposed Key Holder
Transfer; and (ii) forty-five (45) days after delivery of the Proposed Transfer Notice.

 

2.2       Right
of Co-Sale.

 

(a)       Exercise
of Right. If any Transfer Stock subject to a Proposed Key Holder Transfer is not purchased pursuant to Subsection 2.1
above and thereafter is to be sold to a Prospective Transferee, each respective Investor may elect to exercise its Right of Co-Sale
and participate on a pro rata basis in the Proposed Key Holder Transfer as set forth in Subsection 2.2(b) below and, subject
to Subsection 2.2(d), otherwise on the same terms and conditions specified in the Proposed Transfer Notice. Each Investor
who desires to exercise its Right of Co-Sale (each, a “Participating Investor”) must give the selling Key Holder
written notice to that effect within fifteen (15) days after the deadline for delivery of the Secondary Notice described above,
and upon giving such notice such Participating Investor shall be deemed to have effectively exercised the Right of Co-Sale.

 

(b)       Shares
Includable. Each Participating Investor may include in the Proposed Key Holder Transfer all or any part of such Participating
Investor’s Capital Stock equal to the product obtained by multiplying (i) the aggregate number of shares of Transfer
Stock subject to the Proposed Key Holder Transfer (excluding shares purchased by the Company or the Participating Investors pursuant
to the Right of First Refusal or the Secondary Refusal Right) by (ii) a fraction, the numerator of which is the number of shares
of Capital Stock owned by such Participating Investor immediately before consummation of the Proposed Key Holder Transfer (including
any shares that such Investor has agreed to purchase pursuant to the Secondary Refusal Right) and the denominator of which is the
total number of shares of Capital Stock owned, in the aggregate, by all Participating Investors immediately prior to the consummation
of the Proposed Key Holder Transfer (including any shares that all Participating Investors have collectively agreed to purchase
pursuant to the Secondary Refusal Right), plus the number of shares of Transfer Stock held by the selling Key Holder.

 

    	 	5	 

     

    

 

(c)       Purchase
and Sale Agreement. The Participating Investors and the selling Key Holder agree that the terms and conditions of any Proposed
Key Holder Transfer in accordance with Subsection 2.2 will be memorialized in, and governed by, a written purchase and sale
agreement with the Prospective Transferee (the “Purchase and Sale Agreement”) with customary terms and provisions
for such a transaction, and the Participating Investors and the selling Key Holder further covenant and agree to enter into such
Purchase and Sale Agreement as a condition precedent to any sale or other transfer in accordance with this Subsection 2.2.

 

(d)       Allocation
of Consideration.

 

(i)       Subject
to Subsection 2.2(d)(ii), the aggregate consideration payable to the Participating Investors and the selling Key Holder
shall be allocated based on the number of shares of Capital Stock sold to the Prospective Transferee by each Participating Investor
and the selling Key Holder as provided in Subsection 2.2(b), provided that if a Participating Investor wishes to
sell Preferred Stock, the price set forth in the Proposed Transfer Notice shall be appropriately adjusted based on the conversion
ratio of the Preferred Stock into Common Stock.

 

(ii)       In
the event that the Proposed Key Holder Transfer constitutes a Change of Control, the terms of the Purchase and Sale Agreement shall
provide that the aggregate consideration from such transfer shall be allocated to the Participating Investors and the selling Key
Holder in accordance with Sections 2.1 and 2.2 of Article IV(B) of the Restated Certificate as if (A) such transfer were a Deemed
Liquidation Event (as defined in the Restated Certificate), and (B) the Capital Stock sold in accordance with the Purchase and
Sale Agreement were the only Capital Stock outstanding.

 

(e)       Purchase
by Selling Key Holder; Deliveries. Notwithstanding Subsection 2.2(c) above, if any Prospective Transferee or Transferees
refuse(s) to purchase securities subject to the Right of Co-Sale from any Participating Investor or Investors or upon the failure
to negotiate a Purchase and Sale Agreement reasonably satisfactory to the Participating Investors, no Key Holder may sell any Transfer
Stock to such Prospective Transferee or Transferees unless and until, simultaneously with such sale, such Key Holder purchases
all securities subject to the Right of Co-Sale from such Participating Investor or Investors on the same terms and conditions (including
the proposed purchase price) as set forth in the Proposed Transfer Notice and as provided in Subsection 2.2(d)(i); provided,
however, if such sale constitutes a Change of Control, the portion of the aggregate consideration paid by the selling
Key Holder to such Participating Investor or Investors shall be made in accordance with the first sentence of Subsection 2.2(d)(ii).
In connection with such purchase by the selling Key Holder, such Participating Investor or Investors shall deliver to the selling
Key Holder any stock certificate or certificates, properly endorsed for transfer, representing the Capital Stock being purchased
by the selling Key Holder (or request that the Company effect such transfer in the name of the selling Key Holder). Any such shares
transferred to the selling Key Holder will be transferred to the Prospective Transferee against payment therefor in consummation
of the sale of the Transfer Stock pursuant to the terms and conditions specified in the Proposed Transfer Notice, and the selling
Key Holder shall concurrently therewith remit or direct payment to each such Participating Investor the portion of the aggregate
consideration to which each such Participating Investor is entitled by reason of its participation in such sale as provided in
this Subsection 2.2(e).

 

    	 	6	 

     

    

 

(f)       Additional
Compliance. If any Proposed Key Holder Transfer is not consummated within forty-five (45) days after receipt of the Proposed
Transfer Notice by the Company, the Key Holders proposing the Proposed Key Holder Transfer may not sell any Transfer Stock unless
they first comply in full with each provision of this Section 2. The exercise or election not to exercise any right by any
Investor hereunder shall not adversely affect its right to participate in any other sales of Transfer Stock subject to this Subsection 2.2.

 

2.3       Effect
of Failure to Comply.

 

(a)       Transfer
Void; Equitable Relief. Any Proposed Key Holder Transfer not made in compliance with the requirements of this Agreement shall
be null and void ab initio, shall not be recorded on the books of the Company or its transfer agent and shall not be recognized
by the Company. Each party hereto acknowledges and agrees that any breach of this Agreement would result in substantial harm to
the other parties hereto for which monetary damages alone could not adequately compensate. Therefore, the parties hereto unconditionally
and irrevocably agree that any non-breaching party hereto shall be entitled to seek protective orders, injunctive relief and other
remedies available at law or in equity (including, without limitation, seeking specific performance or the rescission of purchases,
sales and other transfers of Transfer Stock not made in strict compliance with this Agreement).

 

(b)       Violation
of First Refusal Right. If any Key Holder becomes obligated to sell any Transfer Stock to the Company or any Investor under
this Agreement and fails to deliver such Transfer Stock in accordance with the terms of this Agreement, the Company and/or such
Investor may, at its option, in addition to all other remedies it may have, send to such Key Holder the purchase price for such
Transfer Stock as is herein specified and transfer to the name of the Company or such Investor (or request that the Company effect
such transfer in the name of an Investor) on the Company’s books any certificates, instruments, or book entry representing
the Transfer Stock to be sold.

 

(c)       Violation
of Co-Sale Right. If any Key Holder purports to sell any Transfer Stock in contravention of the Right of Co-Sale (a “Prohibited
Transfer”), each Investor who desires to exercise its Right of Co-Sale under Subsection 2.2 may, in addition to
such remedies as may be available by law, in equity or hereunder, require such Key Holder to purchase from such Investor the type
and number of shares of Capital Stock that such Investor would have been entitled to sell to the Prospective Transferee had the
Prohibited Transfer been effected in compliance with the terms of Subsection 2.2. The sale will be made on the same terms,
including, without limitation, as provided in Subsection 2.2(d)(i) and the first sentence of Subsection 2.2(d)(ii),
as applicable, and subject to the same conditions as would have applied had the Key Holder not made the Prohibited Transfer, except
that the sale (including, without limitation, the delivery of the purchase price) must be made within ninety (90) days after the
Investor learns of the Prohibited Transfer, as opposed to the timeframe proscribed in Subsection 2.2. Such Key Holder
shall also reimburse each Investor for any and all reasonable and documented out-of-pocket fees and expenses, including reasonable
legal fees and expenses, incurred pursuant to the exercise or the attempted exercise of the Investor’s rights under Subsection
2.2.

 

    	 	7	 

     

    

 

3.            Exempt
Transfers.

 

3.1       Exempted
Transfers. Notwithstanding the foregoing or anything to the contrary herein, the provisions of Subsections 2.1 and 2.2
shall not apply (a) in the case of a Key Holder that is an entity, upon a transfer by such Key Holder to its stockholders, members,
partners or other equity holders, (b) to a repurchase of Transfer Stock from a Key Holder by the Company at a price no greater
than that originally paid by such Key Holder for such Transfer Stock and pursuant to an agreement containing vesting and/or repurchase
provisions approved by a majority of the Board of Directors, (c) to a pledge of Transfer Stock that creates a mere security interest
in the pledged Transfer Stock, provided that the pledgee thereof agrees in writing in advance to be bound by and comply
with all applicable provisions of this Agreement to the same extent as if it were the Key Holder making such pledge, or (d) in
the case of a Key Holder that is a natural person, upon a transfer of Transfer Stock by such Key Holder made for bona fide estate
planning purposes, either during his or her lifetime or on death by will or intestacy to his or her spouse, child (natural or adopted),
or any other direct lineal descendant of such Key Holder (or his or her spouse) (all of the foregoing collectively referred to
as “family members”), or any other person approved by unanimous consent of the Board of Directors of the Company, or
any custodian or trustee of any trust, partnership or limited liability company for the benefit of, or the ownership interests
of which are owned wholly by such Key Holder or any such family members; or (e) to the sale by the Key Holder of up to 10% of the
Transfer Stock held by such Key Holder as of the date that such Key Holder first became party to this Agreement; provided
that in the case of clause(s) (a), (c), (d) or (e), the Key Holder shall deliver prior written notice to the Investors of such
pledge, gift or transfer and such shares of Transfer Stock shall at all times remain subject to the terms and restrictions set
forth in this Agreement and such transferee shall, as a condition to such issuance, deliver a counterpart signature page to this
Agreement as confirmation that such transferee shall be bound by all the terms and conditions of this Agreement as a Key Holder
(but only with respect to the securities so transferred to the transferee), including the obligations of a Key Holder with respect
to Proposed Key Holder Transfers of such Transfer Stock pursuant to Section 2; and provided further in the case of
any transfer pursuant to clause (a) or (d) above, that such transfer is made pursuant to a transaction in which there is no consideration
actually paid for such transfer.

 

3.2       Exempted
Offerings. Notwithstanding the foregoing or anything to the contrary herein, the provisions of Section 2 shall not apply
to the sale of any Transfer Stock (a) to the public in an offering pursuant to an effective registration statement under the Securities
Act of 1933, as amended (a “Public Offering”); or (b) pursuant to a Deemed Liquidation Event (as defined in
the Company’s Certificate of Incorporation).

 

3.3       Prohibited
Transferees. Notwithstanding the foregoing, no Key Holder shall transfer any Transfer Stock to (a) any entity which, in the
determination of the Company’s Board of Directors, directly or indirectly competes with the Company; or (b) any customer,
distributor or supplier of the Company, if the Company’s Board of Directors should determine that such transfer would result
in such customer, distributor or supplier receiving information that would place the Company at a competitive disadvantage with
respect to such customer, distributor or supplier.

 

    	 	8	 

     

    

 

4.            Legend.
Each certificate, instrument, or book entry representing shares of Transfer Stock held by the Key Holders or issued to any permitted
transferee in connection with a transfer permitted by Subsection 3.1 hereof shall be notated with the following legend:

 

THE SALE, PLEDGE, HYPOTHECATION,
OR TRANSFER OF THE SECURITIES REPRESENTED HEREBY IS SUBJECT TO, AND IN CERTAIN CASES PROHIBITED BY, THE TERMS AND CONDITIONS OF
A CERTAIN AMENDED AND RESTATED RIGHT OF FIRST REFUSAL AND CO-SALE AGREEMENT BY AND AMONG THE STOCKHOLDER, THE CORPORATION AND CERTAIN
OTHER HOLDERS OF STOCK OF THE CORPORATION. COPIES OF SUCH AGREEMENT MAY BE OBTAINED UPON WRITTEN REQUEST TO THE SECRETARY OF THE
CORPORATION.

 

Each Key Holder agrees that the Company may
instruct its transfer agent to impose transfer restrictions on the shares notated with the legend referred to in this Section
4 above to enforce the provisions of this Agreement, and the Company agrees to promptly do so. The legend shall be removed
upon termination of this Agreement at the request of the holder.

 

5.            Lock-Up.

 

5.1       Agreement
to Lock-Up. Each Key Holder hereby agrees that it will not, without the prior written consent of the managing underwriter,
during the period commencing on the date of the final prospectus relating to the Company’s initial public offering (the “IPO”)
and ending on the date specified by the Company and the managing underwriter (such period not to exceed one hundred eighty (l80)
days), or such other period as may be requested by the Company or an underwriter to accommodate regulatory restrictions on (1) the
publication or other distribution of research reports; and (2) analyst recommendations and opinions, including, but not limited
to, the restrictions contained in FINRA Rule 2711(f)(4) or NYSE Rule 472(f)(4), or any successor provisions or amendments
thereto), (a) lend, offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or
contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, directly or indirectly,
any shares of Capital Stock held immediately prior to the effectiveness of the registration statement for the IPO; or (b) enter
into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership
of the Capital Stock, whether any such transaction described in clause (a) or (b) above is to be settled by delivery of Capital
Stock or other securities, in cash or otherwise. The foregoing provisions of this Section 5 shall not apply to the sale
of any shares to an underwriter pursuant to an underwriting agreement, and shall only be applicable to the Key Holders if all officers,
directors and holders of more than one percent (1%) of the outstanding Common Stock (after giving effect to the conversion into
Common Stock of all outstanding Preferred Stock) enter into similar agreements. The underwriters in connection with the IPO are
intended third-party beneficiaries of this Section 5 and shall have the right, power and authority to enforce the provisions
hereof as though they were a party hereto. Each Key Holder further agrees to execute such agreements as may be reasonably requested
by the underwriters in the IPO that are consistent with this Section 5 or that are necessary to give further effect thereto.

 

    	 	9	 

     

    

 

5.2       Stop
Transfer Instructions. In order to enforce the foregoing covenant, the Company may impose stop-transfer instructions with respect
to the shares of Capital Stock of each Key Holder (and transferees and assignees thereof) until the end of such restricted period.

 

6.            Miscellaneous.

 

6.1       Term.
This Agreement shall automatically terminate upon the earlier of (a) immediately prior to the consummation of the Company’s
IPO; and (b) the consummation of a Deemed Liquidation Event (as defined in the Restated Certificate).

 

6.2       Stock
Split. All references to numbers of shares in this Agreement shall be appropriately adjusted to reflect any stock dividend,
split, combination or other recapitalization affecting the Capital Stock occurring after the date of this Agreement.

 

6.3       Ownership.
Each Key Holder represents and warrants that such Key Holder is the sole legal and beneficial owner of the shares of Transfer Stock
subject to this Agreement and that no other person or entity has any interest in such shares (other than a community property interest
as to which the holder thereof has acknowledged and agreed in writing to the restrictions and obligations hereunder).

 

6.4       Dispute
Resolution. The parties (a) hereby irrevocably and unconditionally submit to the jurisdiction of the state courts of the Commonwealth
of Massachusetts and to the jurisdiction of the United States District Court for the District of Massachusetts for the purpose
of any suit, action or other proceeding arising out of or based upon this Agreement, (b) agree not to commence any suit, action
or other proceeding arising out of or based upon this Agreement except in the state courts of Massachusetts or the United States
District Court for the District of Massachusetts, and (c) hereby waive, and agree not to assert, by way of motion, as a defense,
or otherwise, in any such suit, action or proceeding, any claim that it is not subject personally to the jurisdiction of the above-named
courts, that its property is exempt or immune from attachment or execution, that the suit, action or proceeding is brought in an
inconvenient forum, that the venue of the suit, action or proceeding is improper or that this Agreement or the subject matter hereof
may not be enforced in or by such court.

 

Waiver
of Jury Trial: EACH PARTY HEREBY WAIVES ITS RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING
OUT OF THIS AGREEMENT, THE OTHER TRANSACTION DOCUMENTS, THE SECURITIES OR THE SUBJECT MATTER HEREOF OR THEREOF. THE SCOPE OF THIS
WAIVER IS INTENDED TO BE ALL-ENCOMPASSING OF ANY AND ALL DISPUTES THAT MAY BE FILED IN ANY COURT AND THAT RELATE TO THE SUBJECT
MATTER OF THIS TRANSACTION, INCLUDING, WITHOUT LIMITATION, CONTRACT CLAIMS, TORT CLAIMS (INCLUDING NEGLIGENCE), BREACH OF DUTY
CLAIMS, AND ALL OTHER COMMON LAW AND STATUTORY CLAIMS. THIS SECTION HAS BEEN FULLY DISCUSSED BY EACH OF THE PARTIES HERETO AND
THESE PROVISIONS WILL NOT BE SUBJECT TO ANY EXCEPTIONS. EACH PARTY HERETO HEREBY FURTHER WARRANTS AND REPRESENTS THAT SUCH PARTY
HAS REVIEWED THIS WAIVER WITH ITS LEGAL COUNSEL, AND THAT SUCH PARTY KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING
CONSULTATION WITH LEGAL COUNSEL.

 

    	 	10	 

     

    

 

The prevailing party shall be entitled to reasonable
attorney’s fees, costs, and necessary disbursements in addition to any other relief to which such party may be entitled.
Each of the parties to this Agreement consents to personal jurisdiction for any equitable action sought in the U.S. District Court
for the District of Massachusetts or any court of the Commonwealth of Massachusetts having subject matter jurisdiction.

 

6.5       Notices.
All notices and other communications given or made pursuant to this Agreement shall be in writing and shall be deemed effectively
given upon the earlier of actual receipt or (a) personal delivery to the party to be notified, (b) when sent, if sent by electronic
mail or facsimile during normal business hours of the recipient, and if not sent during normal business hours, then on the recipient’s
next business day, (c) five (5) days after having been sent by registered or certified mail, return receipt requested, postage
prepaid, or (d) one (1) business day after deposit with a nationally recognized overnight courier, freight prepaid, specifying
next business day delivery, with written verification of receipt. All communications shall be sent to the respective parties at
their address as set forth on Schedule A or Schedule B hereof, as the case may be, or to such email address, facsimile
number or address as subsequently modified by written notice given in accordance with this Section 6.5. If notice is given
to the Company, it shall be sent to SeqLL Inc., 866 E Fifth Street, Unit 2, Boston, MA 02127, Attn: Daniel
R. Jones; and a copy (which shall not constitute notice) shall also be sent to Foley & Lardner LLP, 975 Page Mill Rd.,
Palo Alto, CA 94304, Attn: E. Thom Rumberger Jr., Esq.

 

6.6       Entire
Agreement. This Agreement (including, the Exhibits and Schedules hereto) constitutes the full and entire understanding and
agreement between the parties with respect to the subject matter hereof, and any other written or oral agreement relating to the
subject matter hereof existing between the parties are expressly canceled.

 

6.7       Delays
or Omissions. No delay or omission to exercise any right, power or remedy accruing to any party under this Agreement, upon
any breach or default of any other party under this Agreement, shall impair any such right, power or remedy of such non-breaching
or non-defaulting party nor shall it be construed to be a waiver of any such breach or default, or an acquiescence therein, or
of or in any similar breach or default thereafter occurring; nor shall any waiver of any single breach or default be deemed a waiver
of any other breach or default theretofore or thereafter occurring. Any waiver, permit, consent or approval of any kind or character
on the part of any party of any breach or default under this Agreement, or any waiver on the part of any party of any provisions
or conditions of this Agreement, must be in writing and shall be effective only to the extent specifically set forth in such writing.
All remedies, either under this Agreement or by law or otherwise afforded to any party, shall be cumulative and not alternative.

 

    	 	11	 

     

    

 

6.8       Amendment;
Waiver and Termination. This Agreement may be amended, modified or terminated (other than pursuant to Section 6.1 above)
and the observance of any term hereof may be waived (either generally or in a particular instance and either retroactively or prospectively)
only by a written instrument executed by (a) the Company, (b) the Key Holders holding a majority of the shares of Transfer Stock
then held by all of the Key Holders who are then providing services to the Company as officers, employees or consultants, and (c)
the holders of a majority of the shares of Common Stock issued or issuable upon conversion of the then outstanding shares of Preferred
Stock held by the Investors (voting as a single class and on an as-converted basis). Any amendment, modification, termination or
waiver so effected shall be binding upon the Company, the Investors, the Key Holders and all of their respective successors and
permitted assigns whether or not such party, assignee or other shareholder entered into or approved such amendment, modification,
termination or waiver. Notwithstanding the foregoing, (i) this Agreement may not be amended, modified or terminated and the observance
of any term hereunder may not be waived with respect to any Investor or Key Holder without the written consent of such Investor
or Key Holder unless such amendment, modification, termination or waiver applies to all Investors and Key Holders, respectively,
in the same fashion, and (ii) the consent of the Key Holders shall not be required for any amendment, modification, termination
or waiver if such amendment, modification, termination or waiver does not apply to the Key Holders, and (iii) Schedule A
hereto may be amended by the Company from time to time in accordance with the Purchase Agreement to add information regarding Additional
Purchasers (as defined in the Purchase Agreement) without the consent of the other parties hereto. The Company shall give prompt
written notice of any amendment, modification or termination hereof or waiver hereunder to any party hereto that did not consent
in writing to such amendment, modification, termination or waiver. No waivers of or exceptions to any term, condition or provision
of this Agreement, in any one or more instances, shall be deemed to be, or construed as, a further or continuing waiver of any
such term, condition or provision.

 

6.9       Assignment
of Rights.

 

(a)       The
terms and conditions of this Agreement shall inure to the benefit of and be binding upon the respective successors and permitted
assigns of the parties. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties
hereto or their respective successors and permitted assigns any rights, remedies, obligations, or liabilities under or by
reason of this Agreement, except as expressly provided in this Agreement.

 

(b)       Any
successor or permitted assignee of any Key Holder, including any Prospective Transferee who purchases shares of Transfer Stock
in accordance with the terms hereof, shall deliver to the Company and the Investors, as a condition to any transfer or assignment,
a counterpart signature page hereto pursuant to which such successor or permitted assignee shall confirm their agreement to be
subject to and bound by all of the provisions set forth in this Agreement that were applicable to the predecessor or assignor of
such successor or permitted assignee.

 

    	 	12	 

     

    

 

(c)       The
rights of the Investors hereunder are not assignable without the Company’s written consent (which shall not be unreasonably
withheld, delayed or conditioned), except (i) by an Investor to any Affiliate, or (ii) to an assignee or transferee who acquires
at least 156,250 shares of Capital Stock (as adjusted for any stock combination, stock split, stock dividend, recapitalization
or other similar transaction), it being acknowledged and agreed that any such assignment, including an assignment contemplated
by the preceding clauses (i) or (ii) shall be subject to and conditioned upon any such assignee’s delivery to the Company
and the other Investors of a counterpart signature page hereto pursuant to which such assignee shall confirm their agreement to
be subject to and bound by all of the provisions set forth in this Agreement that were applicable to the assignor of such assignee.

 

(d)       Except
in connection with an assignment by the Company by operation of law to the acquirer of the Company, the rights and obligations
of the Company hereunder may not be assigned under any circumstances.

 

6.10      Severability.
The invalidity or unenforceability of any provision hereof shall in no way affect the validity or enforceability of any other provision.

 

6.11      Additional
Investors. Notwithstanding anything to the contrary contained herein, if the Company issues additional shares of the Company’s
Series A-2 Preferred Stock after the date hereof, any purchaser of such shares of Series A-2 Preferred Stock may become a party
to this Agreement by executing and delivering an additional counterpart signature page to this Agreement and thereafter shall be
deemed an “Investor” for all purposes hereunder.

 

6.12      Governing
Law. This Agreement and any controversy arising out of or relating to this Agreement shall be governed by and construed in
accordance with the General Corporation Law of the State of Delaware as to matters within the scope thereof, and as to all other
matters shall be governed by and construed in accordance with the internal laws of the Commonwealth of Massachusetts, without regard
to conflict of law principles that would result in the application of any law other than the law of the Commonwealth of Massachusetts.

 

6.13      Titles
and Subtitles. The titles and subtitles used in this Agreement are used for convenience only and are not to be considered in
construing or interpreting this Agreement.

 

6.14      Counterparts.
This Agreement may be executed in two (2) or more counterparts, each of which shall be deemed an original, but all of which together
shall constitute one and the same instrument. Counterparts may be delivered via facsimile, electronic mail (including pdf or any
electronic signature complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com)
or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid
and effective for all purposes.

 

6.15      Aggregation
of Stock. All shares of Capital Stock held or acquired by Affiliated entities or persons shall be aggregated together for the
purpose of determining the availability of any rights under this Agreement and such Affiliated persons may apportion such rights
as among themselves in any manner they deem appropriate.

 

6.16      Specific
Performance. In addition to any and all other remedies that may be available at law in the event of any breach of this Agreement,
each Investor shall be entitled to specific performance of the agreements and obligations of the Company and the Key Holders hereunder
and to such other injunction or other equitable relief as may be granted by a court of competent jurisdiction.

 

[Remainder of Page Intentionally Left Blank]

 

    	 	13	 

     

    

 

IN WITNESS WHEREOF, the
parties have executed this Amended and Restated Right of First Refusal and Co-Sale Agreement as of the date first written above.

 

	 	SEQLL INC.
	 	 
	 	By:	/s/ Elizabeth Reczek
	 	Name: Elizabeth Reczek
	 	 
	 	Title:  Chief Executive Officer

 

	 	KEY HOLDERS:
	 	 
	 	DANIEL JONES
	 	 
	 	Signature:	/s/ Daniel Jones
	 	Name: Daniel Jones

 

	 	TISHA JEPSON
	 	 
	 	Signature:	/s/ Tisha Jepson
	 	Name: Tisha Jepson

 

	 	WENDY ST. LAURENT
	 	 
	 	Signature:	/s/ Wendy St. Laurent
	 	Name: Wendy St. Laurent

 

	 	PETER BRENNAN
	 	 
	 	Signature:	/s/ Peter Brennan
	 	Name: Peter Brennan

  

Signature
Page To Right Of First Refusal And Co-Sale Agreement

 

    			 

     

    

 

IN WITNESS WHEREOF, the
parties have executed this Amended and Restated Right of First Refusal and Co-Sale Agreement as of the date first written above.

 

	 	INVESTOR:
	 	 
	 	GENOMIC DIAGNOSTIC TECHNOLOGIES, INC.
	 	 	 
	 	By:	/s/ William St. Laurent , PRES.
	 	 	 
	 	Name:	 
	 	 	 
	 	 	William St. Laurent, President

 

Signature
Page To Right Of First Refusal And Co-Sale Agreement

 

    			 

     

    

 

IN WITNESS WHEREOF, the
parties have executed this Amended and Restated Right of First Refusal and Co-Sale Agreement as of the date first written above.

 

	 	INVESTOR:
	 	 
	 	/s/ Eleanor St. Laurent
	 	Eleanor St. Laurent
	 	Address: 120 NE 136th Ave., Suite 200, 
	 	Vancouver, WA 98684

 

Signature
Page To Right Of First Refusal And Co-Sale Agreement

 

    			 

     

    

 

IN WITNESS WHEREOF, the
parties have executed this Amended and Restated Right of First Refusal and Co-Sale Agreement as of the date first written above.

 

	 	INVESTOR:
	 	 
	 	/s/ Georges C. St. Laurent
	 	Georges C. St. Laurent, III
	 	Address: 375 Commerce Way, Suite 101, 
	 	Longwood, FL 32750

 

Signature
Page To Right Of First Refusal And Co-Sale Agreement

 

    			 

     

    

 

IN WITNESS WHEREOF, the
parties have executed this Amended and Restated Right of First Refusal and Co-Sale Agreement as of the date first written above.

 

	 	INVESTOR:
	 	 
	 	/s/ Georges C. St. Laurent, Jr.
	 	Georges C. St. Laurent, Jr.
	 	Address: 120 NE 136th Ave., Suite 200, 
	 	Vancouver, WA 98684

 

Signature
Page To Right Of First Refusal And Co-Sale Agreement

 

    			 

     

    

 

IN WITNESS WHEREOF, the
parties have executed this Amended and Restated Right of First Refusal and Co-Sale Agreement as of the date first written above.

 

	 	INVESTOR:
	 	 	 
	 	FLORENCE H JONES REV TRUST U/A 07/22/03
	 	 	 
	 	By:	/s/ Florence H. Jones
	 	 	 
	 	Name: Florence H. Jones
	 	 	 
	 	Title: Trustee
	 	 	 
	 	By:	/s/ Robert P. Jones
	 	 	 
	 	Name: Robert P. Jones
	 	 	 
	 	Title: Trustee

 

Signature
Page To Right Of First Refusal And Co-Sale Agreement

 

     

     

    

 

IN WITNESS WHEREOF, the
parties have executed this Amended and Restated Right of First Refusal and Co-Sale Agreement as of the date first written above.

 

	 	INVESTOR:
	 	 
	 	/s/ Tisha Jepson
	 	Tisha Jepson
	 	Address: 3732 Manor Road, #4,

Chevy Chase, MD 20815

 

Signature
Page To Right Of First Refusal And Co-Sale Agreement

 

    			 

     

    

 

IN WITNESS WHEREOF, the
parties have executed this Amended and Restated Right of First Refusal and Co-Sale Agreement as of the date first written above.

 

	 	INVESTOR:
	 	 
	 	PROVIDENT TRUST, LLC FBO: TISHA JEPSON ROTH IRA

 

	 	By:	/s/ Theresa Fette
	 	 
	 	Name:	Theresa Fette
	 	 
	 	Title:	CEO

 

Signature
Page To Right Of First Refusal And Co-Sale Agreement

 

    			 

     

    

 

IN WITNESS WHEREOF, the
parties have executed this Amended and Restated Right of First Refusal and Co-Sale Agreement as of the date first written above.

 

	 	INVESTOR:
	 	 
	 	THE JAMES P MISCOLL BYPASS TRUST
	 	 
	 	By:	/s/ Douglas Miscoll
	 	 
	 	Name: Douglas Miscoll
	 	 
	 	Title: Trustee

 

Signature
Page To Right Of First Refusal And Co-Sale Agreement

 

    			 

     

    

 

IN WITNESS WHEREOF, the
parties have executed this Amended and Restated Right of First Refusal and Co-Sale Agreement as of the date first written above.

 

	 	INVESTOR:
	 	/s/ Bruce Block
	 	Bruce T. Block
	 	Address: 9300 North Regent Road
	 	Bayside, WI 53217

 

Signature
Page To Right Of First Refusal And Co-Sale Agreement

 

     

     

    

 

IN WITNESS WHEREOF, the
parties have executed this Amended and Restated Right of First Refusal and Co-Sale Agreement as of the date first written above.

 

	 	INVESTOR:
	 	 
	 	GEORGES C. ST. LAURENT, III DESCENDANTS’ TRUST
	 	 	 
	 	By:	 /s/ William St. Laurent
	 	 	 
	 	Name: William St. Laurent
	 	 
	 	Title: Trustee

 

Signature
Page To Right Of First Refusal And Co-Sale Agreement

 

     

     

    

 

IN WITNESS WHEREOF, the
parties have executed this Amended and Restated Right of First Refusal and Co-Sale Agreement as of the date first written above.

 

	 	INVESTOR:
	 	 
	 	WILLIAM C. ST. LAURENT DESCENDANTS’ TRUST
	 	 
	 	By:	/s/ William St. Laurent
	 	 	 
	 	Name: William St. Laurent
	 	 
	 	Title: Trustee

 

Signature
Page To Right Of First Refusal And Co-Sale Agreement

 

    			 

     

    

 

SCHEDULE A

 

INVESTORS

 

	Name and Address	 	Number and Class of Shares Held
	Genomic Diagnostic Technologies, Inc. 

375 Commerce Way

Suite 101

Longwood, Florida 32750	 	1,562,500 Series A-1
	Eleanor St. Laurent

120 NE 136th Ave.

Suite 200

Vancouver, WA 98684	 	312,500 Series A-1
	Georges C. St. Laurent, Jr.

120 NE 136th Ave. 

Suite 200

Vancouver, WA 98684	 	781,250 Series A-1
	Georges C. St. Laurent, III

375 Commerce Way 

Suite 101 

Longwood, FL 32750	 	31,250 Series A-1*
	FLORENCE H JONES REV TRUST U/A 07/22/03

104 Pelczar Road 

Dracut, MA 01826	 	62,500 Series A-1
	Tisha Jepson

3732 Manor Road, #4

Chevy Chase, MD 20815	 	78,125 Series A-1
	PROVIDENT TRUST, LLC FBO: TISHA JEPSON ROTH IRA

880 Sunset Road

Suite #250

Las Vegas, Nevada 89148	 	156,250 Series A-1
	THE JAMES P MISCOLL BYPASS TRUST

146 W. Bellevue Avenue

San Mateo, CA 94402	 	78,125 Series A-1
	Bruce T. Block

9300 North Regent Road

Bayside, WI 53217	 	62,500 Series A-1
	Georges C. St. Laurent, III Descendants' Trust 

120 NE 136th Ave, Suite 200

Vancouver,  WA 98684	 	297,619 Series A-2
	William C. St. Laurent Descendants' Trust 

120 NE 136th Ave, Suite 200

Vancouver,  WA 98684	 	297,619 Series A-2

 

* Shares currently held by the estate of Georges C. St. Laurent
III, but such shares are to be transferred to Lucas Campbell and William Campbell upon completion of the estate’s probate
process.

 

     

     

    

 

SCHEDULE B

 

KEY HOLDERS

 

	Name and Address	 	Number of Shares Held
	 	 	 
	Daniel Jones	 	4,491,000
	866 East 5th Street	 	 
	Unit 2	 	 
	Boston, MA 02127	 	 
	 	 	 
	Wendy St. Laurent.	 	2,198,250
	841 Mayfield Ave.	 	 
	Winter Park, FL 32789	 	 
	 	 	 
	Tisha Jepson	 	90,000
	3732 Manor Road, #4	 	 
	Chevy Chase, MD 20815	 	 
	 	 	 
	Ethan Neal	 	90,000
	3732 Manor Road, #4	 	 
	Chevy Chase, MD 20815	 	 
	 	 	 
	Peter Brennan	 	45,000
	 	 	 
	Georges C. St. Laurent, III	 	2,198,250*
	375 Commerce Way	 	 
	Suite 101	 	 
	Longwood, FL 32750	 	 

 

* Shares currently held by the estate of Georges C. St. Laurent
III, but such shares are to be transferred to Lucas Campbell and William Campbell upon completion of the estate’s probate
process.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00294-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00294-of-00352.parquet"}]]